Medinova Diagnostic Services Ltd
₹ 40.5
-0.02%
22 Nov
- close price
About
Incorporated in 1985, Medinova Diagnostic Services Ltd is in the business of providing diagnostic services.
Key Points
- Market Cap ₹ 40.4 Cr.
- Current Price ₹ 40.5
- High / Low ₹ 64.5 / 28.5
- Stock P/E 48.7
- Book Value ₹ -1.65
- Dividend Yield 0.00 %
- ROCE 55.6 %
- ROE %
- Face Value ₹ 10.0
Pros
Cons
- The company has delivered a poor sales growth of 2.91% over past five years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Healthcare Industry: Healthcare
Loading peers table ...
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10.48 | 9.59 | 7.00 | 6.45 | 6.01 | 6.68 | 6.74 | 5.49 | 11.32 | 11.51 | 7.76 | 7.78 | 7.58 | |
| 10.05 | 9.98 | 10.28 | 6.93 | 6.66 | 6.87 | 6.43 | 5.19 | 8.69 | 8.47 | 6.27 | 6.29 | 6.04 | |
| Operating Profit | 0.43 | -0.39 | -3.28 | -0.48 | -0.65 | -0.19 | 0.31 | 0.30 | 2.63 | 3.04 | 1.49 | 1.49 | 1.54 |
| OPM % | 4.10% | -4.07% | -46.86% | -7.44% | -10.82% | -2.84% | 4.60% | 5.46% | 23.23% | 26.41% | 19.20% | 19.15% | 20.32% |
| -0.03 | 1.36 | 0.33 | 0.24 | 1.84 | 1.55 | 1.78 | 0.26 | 0.29 | 0.22 | 0.23 | 0.26 | 0.24 | |
| Interest | 0.07 | 0.10 | 0.23 | 0.41 | 0.62 | 0.48 | 0.43 | 0.42 | 0.31 | 0.45 | 0.61 | 0.61 | 0.53 |
| Depreciation | 0.59 | 0.58 | 1.03 | 0.81 | 1.25 | 0.86 | 0.55 | 0.41 | 0.32 | 0.26 | 0.24 | 0.12 | 0.13 |
| Profit before tax | -0.26 | 0.29 | -4.21 | -1.46 | -0.68 | 0.02 | 1.11 | -0.27 | 2.29 | 2.55 | 0.87 | 1.02 | 1.12 |
| Tax % | -7.69% | 106.90% | -14.73% | 8.90% | -14.71% | -50.00% | 30.63% | 11.11% | 5.68% | 18.82% | 27.59% | 25.49% | |
| -0.24 | -0.02 | -3.59 | -1.60 | -0.58 | 0.03 | 0.77 | -0.30 | 2.17 | 2.07 | 0.63 | 0.75 | 0.83 | |
| EPS in Rs | -0.25 | -0.02 | -3.79 | -1.69 | -0.58 | 0.03 | 0.77 | -0.30 | 2.17 | 2.07 | 0.63 | 0.75 | 0.83 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -2% |
| 5 Years: | 3% |
| 3 Years: | -12% |
| TTM: | -4% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 24% |
| 3 Years: | -30% |
| TTM: | 11% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 22% |
| 3 Years: | 3% |
| 1 Year: | 41% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 9.46 | 9.46 | 9.46 | 9.46 | 9.96 | 9.96 | 9.96 | 9.96 | 9.96 | 9.96 | 9.96 | 9.96 | 9.96 |
| Reserves | -12.63 | -12.65 | -16.24 | -17.83 | -17.93 | -18.09 | -17.33 | -17.63 | -15.52 | -13.43 | -12.79 | -12.02 | -11.61 |
| 16.31 | 0.34 | 1.44 | 4.69 | 5.08 | 4.75 | 4.48 | 4.34 | 3.27 | 5.75 | 5.75 | 5.00 | 5.00 | |
| 9.29 | 9.93 | 10.58 | 12.12 | 9.24 | 8.28 | 7.09 | 7.35 | 6.93 | 4.40 | 3.41 | 3.08 | 3.11 | |
| Total Liabilities | 22.43 | 7.08 | 5.24 | 8.44 | 6.35 | 4.90 | 4.20 | 4.02 | 4.64 | 6.68 | 6.33 | 6.02 | 6.46 |
| 5.56 | 4.28 | 1.07 | 4.33 | 3.22 | 1.84 | 1.44 | 1.03 | 0.90 | 0.80 | 0.95 | 1.02 | 1.29 | |
| CWIP | 0.32 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.88 | 0.94 | 1.15 | 1.29 | 1.27 | 1.27 | 1.27 | 2.97 | 2.97 | 2.97 | 2.97 |
| 16.55 | 2.80 | 3.29 | 3.17 | 1.98 | 1.77 | 1.49 | 1.72 | 2.47 | 2.91 | 2.41 | 2.03 | 2.20 | |
| Total Assets | 22.43 | 7.08 | 5.24 | 8.44 | 6.35 | 4.90 | 4.20 | 4.02 | 4.64 | 6.68 | 6.33 | 6.02 | 6.46 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 1.70 | -0.19 | 1.76 | -0.69 | 0.36 | 0.52 | 0.42 | 1.51 | 1.13 | 1.18 | 1.51 | |
| 0.00 | 1.04 | -1.29 | -4.17 | -0.31 | 0.23 | -0.13 | -0.14 | -0.11 | -1.84 | -0.34 | -0.18 | |
| 0.00 | -2.76 | 1.46 | 2.48 | 0.97 | -0.56 | -0.43 | -0.27 | -1.15 | 0.94 | -0.78 | -1.32 | |
| Net Cash Flow | 0.00 | -0.02 | -0.01 | 0.06 | -0.03 | 0.02 | -0.04 | 0.01 | 0.25 | 0.24 | 0.06 | 0.00 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 64.43 | 31.97 | 37.54 | 26.60 | 18.22 | 9.29 | 21.66 | 20.61 | 24.83 | 15.86 | 31.51 | 17.36 |
| Inventory Days | 88.85 | 32.28 | 86.45 | 56.15 | 29.80 | 20.77 | ||||||
| Days Payable | 268.95 | 369.97 | 1,349.54 | 1,644.51 | 1,512.14 | 1,261.18 | ||||||
| Cash Conversion Cycle | -115.67 | -305.72 | -1,225.55 | -1,561.75 | -1,464.13 | -1,231.12 | 21.66 | 20.61 | 24.83 | 15.86 | 31.51 | 17.36 |
| Working Capital Days | -160.56 | -255.77 | -411.41 | -570.42 | -510.15 | -402.16 | -351.46 | -459.41 | -181.86 | -106.55 | -107.24 | -108.37 |
| ROCE % | -0.53% | -17.30% | 56.92% | 55.63% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)
16 Nov - Resignation of CFO Nikhil Rajmal Jain effective November 30, 2024.
- Announcement under Regulation 30 (LODR)-Newspaper Publication 30 Oct
-
Board Meeting Outcome for Outcome Of Board Meeting Held On 29Th October 2024
29 Oct - Approval of Q2 and half-year financial results.
- Un-Audited Financial Results For The Quarter Ended September 30, 2024 29 Oct
-
Board Meeting Intimation for To Consider And Approve The Standalone And Consolidated Unaudited Financial Results Of The Company For The Second Quarter And Half Year Ended September 30, 2024; And Other Corporate Matters
19 Oct - Board meeting scheduled to approve financial results.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Services Offered:[1]
Company has four centers situated at Hyderabad, Pune and Kolkata which offers services ranging from an blood test to a CT/MRI Scan. Investigations are broadly classified as Lab, Pathological, Radiology, Imageology, Cardiology and Gastroscopy. Other services include:
a) Master Health Check Up
b) Executive Health Check Up
c) Well Woman Check Up
d) Cardiac Profile
e) Diabetic Profile
f) Corporate Services
g) Home visits
h) Ambulance Services
i) Health Camps
Company is also expanding its services to Executives, Government Employees, Industrial workers etc., through various tie-ups.